Viropro Inc.

Viropro, Inc. (Viropro) is a publicaly held pharmaceutical company engaged in cell line and business development process. The company markets with unmet medical needs for the treatment of various diseases like cancer, diabetes, multiple sclerosis, chronic hepatitis and rheumatoid arthritis. The services offered by Viropro include mammailian cell line development, cell line stability determination and mass spectrometry services for protein sequencing and characterization. The company has an agreement with the Biotechnological Research Institute of the National Council of Canada for the production of human interferon beta and purification process development. Viropro is into partnership with Biologics Process Development Inc., NRC-BRI and Intas Biopharmaceuticals. The company operates through its subsidiary Viropro International, Inc. Viropro is headquartered in Quebec, Canada.

Street: 
300 Chemin des Sommets
City: 
Verdun
Postcode: 
H3E 2B7
Federal State : 
Canada
WebSite: 
www.viropro.com

Company Index Score

Current Index Score Historical Index Score
  • Viropro Inc. currently scores 50 % in the index.
  • Viropro Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Viropro Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets